title: Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes.
authors.forename: A
authors.initials: A
authors.lastname: Candoni
authors.forename: A
authors.initials: A
authors.lastname: Raza
authors.forename: F
authors.initials: F
authors.lastname: Silvestri
authors.forename: L
authors.initials: L
authors.lastname: Lisak
authors.forename: N
authors.initials: N
authors.lastname: Galili
authors.forename: M
authors.initials: M
authors.lastname: Mumtaz
authors.forename: F
authors.initials: F
authors.lastname: Kikic
authors.forename: R
authors.initials: R
authors.lastname: Fanin
mesh_terms: D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality*; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide